(now Germany)"},"field":{"wt":"[[Developmental Biology]]"},"students":{"wt":""},"alma_mater":{"wt":"[[Technische Universität Darmstadt]]"},"work_institutions":{"wt":"[[Max Planck Institute for Biophysical Chemistry]]
[[Max Planck Society]]
[[Okinawa Institute of Science and Technology]]"},"prizes":{"wt":"[[Louis-Jeantet Prize for Medicine]] (1995){{Cite web|url=https://www.jeantet.ch/en/prix-louis-jeantet/laureats/1995-en/professeur-peter-gruss/|title=Professor Peter GRUSS |Jeantet|date=October 1,2017}}"},"website":{"wt":"{{URL|https://www.oist.jp/message-president}}"},"footnotes":{"wt":""}},"i":0}}]}" id="mwBA">.mw-parser-output .infobox-subbox{padding:0;border:none;margin:-3px;width:auto;min-width:100%;font-size:100%;clear:none;float:none;background-color:transparent}.mw-parser-output .infobox-3cols-child{margin:auto}.mw-parser-output .infobox .navbar{font-size:100%}@media screen{html.skin-theme-clientpref-night .mw-parser-output .infobox-full-data:not(.notheme)>div:not(.notheme)[style]{background:#1f1f23!important;color:#f8f9fa}}@media screen and (prefers-color-scheme:dark){html.skin-theme-clientpref-os .mw-parser-output .infobox-full-data:not(.notheme) div:not(.notheme){background:#1f1f23!important;color:#f8f9fa}}@media(min-width:640px){body.skin--responsive .mw-parser-output .infobox-table{display:table!important}body.skin--responsive .mw-parser-output .infobox-table>caption{display:table-caption!important}body.skin--responsive .mw-parser-output .infobox-table>tbody{display:table-row-group}body.skin--responsive .mw-parser-output .infobox-table tr{display:table-row!important}body.skin--responsive .mw-parser-output .infobox-table th,body.skin--responsive .mw-parser-output .infobox-table td{padding-left:inherit;padding-right:inherit}}
Peter Gruss | |
---|---|
![]() | |
Born | |
Alma mater | Technische Universität Darmstadt |
Awards | Louis-Jeantet Prize for Medicine (1995) [1] |
Scientific career | |
Fields | Developmental Biology |
Institutions | Max Planck Institute for Biophysical Chemistry Max Planck Society Okinawa Institute of Science and Technology |
Website | www |
Peter Gruss (born 28 June 1949) is a German developmental biologist, president of the Okinawa Institute of Science and Technology, [2] and the former president of the Max-Planck-Gesellschaft [3] (having been elected for the term from 2002 to 2008 and reelected for 2008–2014).
Gruss's research has generally covered the topic of control mechanisms in the development of mammals, especially in the development of the nervous system. He has been able to produce insulin using stem cells.
Gruss grew up in the town of Alsfeld in the German state of Hesse. After gaining his university-entrance qualification (Abitur), he embarked on a degree in biology at Darmstadt University of Technology in 1968, graduating from the Institute of Microbiology in 1973. From 1974 to 1977, Peter Gruss worked on his Ph.D. on the subject of a tumor virus at the Institute for Virus Research at the German Cancer Research Center (DKFZ) in Heidelberg. He then spent a year as an assistant at the German Cancer Research Center. In 1978, he went to the US as a post doc in receipt of a fellowship grant to continue studying tumor viruses at the Cancer Institute of the National Institutes of Health (NIH) in Bethesda/Maryland.
From 1982 to 1986, Gruss was a professor at the University of Heidelberg's Institute of Microbiology. He was on the board of directors of the university's molecular biology institute, the ZMBH, from 1983. During this time, he organised several international molecular biology symposia. In 1986, Gruss was appointed a scientific member and director of the Department of Molecular Cell Biology at the Max Planck Institute for Biophysical Chemistry in Göttingen.
He is honorary professor at University of Göttingen. [4] He is a member of the board at Deutsche Venture Capital, and chairman of DeveloGen. [5]
In early 2015, Gruss has begun to develop the "Siemens Technology & Innovation Council" (STIC), which is an advisory board intended discuss technologies and innovations that will play a significant role for Siemens over the next ten years and beyond. Gruss chairs the council and decides on its orientation. [6] [7] [8]
Gruss's work focused on gene regulation processes. He was particularly interested in the genetic and cellular-biological building blocks that switch genetic programmes on and off in tumour viruses and in the course of embryonic development. In experiments on mice, he successfully identified significant controlling genes (known as Pax genes) which regulate the development of various organs. A study of the pancreas which he conducted enabled him to detect genes involved in the development of insulin-producing islets of Langerhans. This also provided the basis for differentiating stem cells in insulin-producing cells. [9]
Upon taking office, Gruss was regarded by the press as an "American-style man of action" and an "unassuming high flyer". [10] [11] [12]
In his inaugural speech, Gruss focused on the financial scope for science: he called for the introduction of a collective bargaining law specifically for the field of science to enable Germany to attract the world's best scientists. He also spoke out in favour of a reliable financial framework: "Only adequate rates of increase – predefined for a lengthy period of time – for the budget of the MPS can guarantee planning security". [13] The institutes were faced with potentially having to make cuts in their budgets after the Society's budget had not been raised as much as requested in past years.
Gruss pointed out on numerous occasions that the appointment of directors at the Max Planck Society involved competing with some of the world's leading research institutions: "Yet we at Max Planck are not competing with the average – we are competing with the Harvards, the Cambridges and ETH Zurichs of this world". [14] He went on to say that Germany was not internationally competitive when it came to pay, but that the Max Planck Society was largely able to offset this disadvantage due to the support it enjoyed from the Max Planck Foundation and thanks to its world-renowned planning security. [15] A first step towards improving the financial conditions for top scientists from overseas was the Freedom of Science Initiative of the German Government, which has offered non-university research institutions new financial freedoms since 2009. [16]
During Gruss's term in office, numerous institutes were reorganised or newly established: The MPI for Research on Collective Goods and the MPI for Ornithology had their status raised from research group to institute; the MPI for History was reorganised to become the MPI for the Study of Religious and Ethnic Diversity, while the MPI for Biology of Ageing and the MPI for the Science of Light were newly established. [17] The Max Planck Florida Institute marks the first institute of the Max Planck Society to be established outside of Europe; it is funded by the State of Florida and the local county. Furthermore, the MPI for Metals Research was converted to the MPI for Intelligent Systems and a sub-section of the institute was newly established at Tübingen. [18]
The Lead Discovery Center was founded as a new subsidiary in Dortmund in 2008 to improve the technology transfer of newly developed pharmaceutical drugs. [19]
The Society's international networking is particularly successful: After the publication of news on the foundation of the Florida Institute, which came to be seen as a "model", the German news magazine Der Spiegel reported that the MPS had received requests from Canada and South Korea to establish institutes there. [20] More than 40 per cent of the recently appointed Directors at the MPS are from outside of Germany, and 25 per cent of all Directors in the Max Planck Society are of non-German origin. [21]
In an interview published by Spiegel Online , Gruss outlined a new strategy for establishing "Max Planck Centers" for cooperating with foreign research institutions; some of these are already in place in cities like Shanghai, Buenos Aires and New Delhi. [22]
Gruss championed the cause of transferring his findings into practical application: he co-funded the biopharmaceutical company DeveloGen AG in Göttingen (now part of Evotec) in 1997, together with fellow developmental biologists Herbert Jaeckle (Max Planck Society), Wolfgang Driever (University of Freiburg) and the entrepreneur Herbert Stadler. The company concentrated on developing new treatments for metabolic and endocrinological diseases with a special focus on diabetes. [23]
Gruss has won various awards for his research. In 1994 he was awarded the most highly endowed prize in German science, the Gottfried Wilhelm Leibniz Prize of the Deutsche Forschungsgemeinschaft. In 1995 he received the prestigious Louis-Jeantet Prize for Medicine. [1] In 1999, he was honored with the German Future Prize (the Federal President's Prize for Science and Technology) for his studies in molecular biology and the potential development of therapeutic procedures which they enabled. He received this prize together with Herbert Jäckle. [24] Gruss received the Officer's Cross of the Order of Merit of the Federal Republic of Germany in 2009. [25]
Some of his other awards are [27]
"Archived copy" (PDF). Archived from the original (PDF) on 2012-01-18. Retrieved 2012-01-31.{{cite web}}
: CS1 maint: archived copy as title (link)</ref>
Gruss is a member of various national and international research committees, among others:
Other organisations of which he is a member are:
Manfred Eigen was a German biophysical chemist who won the 1967 Nobel Prize in Chemistry for work on measuring fast chemical reactions.
The Max Planck Society for the Advancement of Science is a formally independent non-governmental and non-profit association of German research institutes. Founded in 1911 as the Kaiser Wilhelm Society, it was renamed to the Max Planck Society in 1948 in honor of its former president, theoretical physicist Max Planck. The society is funded by the federal and state governments of Germany.
Bert Sakmann is a German cell physiologist. He shared the Nobel Prize in Physiology or Medicine with Erwin Neher in 1991 for their work on "the function of single ion channels in cells," and the invention of the patch clamp. Bert Sakmann was Professor at Heidelberg University and is an Emeritus Scientific Member of the Max Planck Institute for Medical Research in Heidelberg, Germany. Since 2008 he leads an emeritus research group at the Max Planck Institute of Neurobiology.
The Kaiser Wilhelm Society for the Advancement of Science was a German scientific institution established in the German Empire in 1911. Its functions were taken over by the Max Planck Society. The Kaiser Wilhelm Society was an umbrella organisation for many institutes, testing stations, and research units created under its authority.
The Max Planck Institute for Informatics is a research institute in computer science with a focus on algorithms and their applications in a broad sense. It hosts fundamental research as well a research for various application domains.
The Max Planck Institute for Biophysical Chemistry, also known as the Karl-Friedrich Bonhoeffer Institute, was a research institute of the Max Planck Society, located in Göttingen, Germany. On January 1, 2022, the institute merged with the Max Planck Institute for Experimental Medicine in Göttingen to form the Max Planck Institute for Multidisciplinary Sciences.
Patrick Cramer is a German chemist, structural biologist, and molecular systems biologist. In 2020, he was elected an international member of the National Academy of Sciences. He became president of the Max Planck Society in June 2023.
The Max Planck Institute for Molecular Biomedicine was founded on 1 April 2001 in Münster, North Rhine-Westphalia, Germany. It is part of the Max Planck Society. The current managing director is professor Sara Wickström.
The Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG) is a biology research institute located in Dresden, Germany. It was founded in 1998 and was fully operational in 2001. Research groups in the institute work in molecular biology, cell biology, developmental biology, biophysics, systems biology, and mathematics supported by various facilities.
The Max Planck Institute for Terrestrial Microbiology is a research institute for terrestrial microbiology in Marburg, Germany. It was founded in 1991 by Rudolf K. Thauer and is one of 80 institutes in the Max Planck Society (Max-Planck-Gesellschaft). Its sister institute is the Max Planck Institute for Marine Microbiology, which was founded a year later in 1992 in Bremen.
The Max Planck Institute of Microstructure Physics in Halle (Saale) is a research institute in Germany focused novel materials with useful functionalities. Active research topics includes spintronics, neuromorphic systems, nano-photonics, topological metals and insulators etc. It was founded in 1992 by Hellmut Fischmeister and is a follow-up to the German Academy of Sciences Institute of Solid State Physics and Electron Microscopy. The institute moved into new buildings from 1997 till 1999. It is one of 84 institutes in the Max Planck Society (Max-Planck-Gesellschaft).
Reinhard Genzel is a German astrophysicist, co-director of the Max Planck Institute for Extraterrestrial Physics, a professor at LMU and an emeritus professor at the University of California, Berkeley. He was awarded the 2020 Nobel Prize in Physics "for the discovery of a supermassive compact object at the centre of our galaxy", which he shared with Andrea Ghez and Roger Penrose. In a 2021 interview given to Federal University of Pará in Brazil, Genzel recalls his journey as a physicist; the influence of his father, Ludwig Genzel; his experiences working with Charles H. Townes; and more.
Günther Wilke was a German chemist who was influential in organometallic chemistry. He was the director of the Max Planck Institute for Coal Research from 1967–1992, succeeding Karl Ziegler in that post. During Wilke's era, the MPI made several discoveries and achieved some financial independence from patents and a gift from the Ziegler family. The institute continued as a center of excellence in organometallic chemistry.
The Max Planck Institute for the Physics of Complex systems is one of the 80 institutes of the Max-Planck-Gesellschaft, located in Dresden, Germany.
Roger Sidney Goody is an English chemist who served as director at the Max Planck Institute for Molecular Physiology in Dortmund from 1993 until 2013. Since 2013 he is Emeritus Director of the institute.
Claudia Felser is a German solid state chemist and materials scientist. She is currently a director of the Max Planck Institute for Chemical Physics of Solids. Felser was elected as a member into the National Academy of Engineering in 2020 for the prediction and discovery of engineered quantum materials ranging from Heusler compounds to topological insulators.
Petra Schwille is a German professor and a researcher in the area of biophysics. Since 2011, she has been a director of the Department of Cellular and Molecular Biophysics at the Max Planck Institute for Biochemistry in Martinsried, Germany. She is known for her ground-laying work in the field of fluorescence cross-correlation spectroscopy, and numerous contributions on model membranes. Her current research focuses around bottom-up approaches to building an artificial cell within a broader area of synthetic biology. In 2010, Schwille received the Gottfried Wilhelm Leibniz Prize.
Thomas Lengauer is a German computer scientist and computational biologist.
Elena Conti is an Italian biochemist and molecular biologist. She serves as Director and Scientific Member of the Max Planck Institute of Biochemistry in Martinsried, Germany, where she uses structural biology and biophysical techniques to study RNA transport and RNA metabolism. Together with Elisa Izaurralde, she helped characterize proteins important for exporting mRNA out of the nucleus.
Dirk Görlich, born October 18, 1966, in Halle (Saale) of Germany, is a German biochemist. He is now director at the Max Planck Institute for Multidisciplinary Sciences in Göttingen.
{{cite web}}
: CS1 maint: archived copy as title (link)